• Medical_Professionals
• Medical_students
• Nurses

The issue of antibacterial resistance is becoming increasingly prevalent within the world of modern medicine. Difficult-to-treat pathogens create an incredibly real issue within clinical environments; and the problem needs to be addressed with novel treatments and the development of mechanisms which circumvent current therapeutic barriers.

To address the ever-growing need of informative and thought provoking discussion, in order to address these industry issues, Superbugs & Superdrugs USA conference will offer a jam-packed agenda with presentations from key industry leaders and up-and-coming thinkers, within the field.

By attending our 3rd annual Superbugs & Superdrugs USA event, not only would you benefit from the knowledge delivered through range of thought-provoking presentations, by experts at the forefront of the field; but you would also receive the opportunity to interact with and exchange ideas with decision makers from all of the different facets of the industry – from research to commercial providers and regulatory bodies

What our attendees said last year:

"Very interesting range of speakers and topics - really looking forward to the 2018 event!"

"The chairs did a great job of moderating - great discussion"

This years' Superbugs & Superdrugs USA Conference will help you to:

Gain insight into Diagnostic Technologies being used in the field and the futuristic developments which could be implemented.

Network with key industry leaders and benefit from though provoking discussions

Hear from the main regulatory bodies to advise on guidelines surrounding funding and development

Listen to up-and-coming companies, developing novel approaches to circumvent antibacterial resistance

Discover new approaches of anti-fungal development

Chief Scientific Officer, Chief operating officer, Chief Medical Officer, Research and Development Manager, Research and Development Director, Research and Development Scientist, Research Assistant, Research Technologist, Professors, Doctors, Research Scientist, PhD student, Research Fellow, Principal Lecturers, Sales Directors, Business Development, Marketing Director, Business Coordinators, Engagement Manager

Achaogen Inc; Amplyx Pharmaceuticals, Inc; Battelle; Centauri Therapeutics; CLINIC; ContraFect; ContraFect Corporation; DeNovaMed Inc; Emergent BioSolutions; Emergent BioSolutions Inc.; Evotec; F2G Ltd; FDA; Forge Therapeutics, Inc.; FUJIFILM Diosynth Biotechnologies; HHS/ASPR/BARDA; Janssen Research & Development, LLC; Laboratoire Biodim; Lovelace Respiratory Research Institute; Macrolide Pharmaceuticals, Inc.; MDLinx; Mdlinx Inc; MedImmune; Merck; Merck & Co.; Microbiotix Inc; Micromyx LLC; Micron Research; Morton Findlay Associates Ltd; Motif BioSciences; N8 Medical LLC; NeoSome Life Sciences, LLC; Nobelex Biotech; Novo AS; Pfizer; Prodigy Biotechnology; Rutgers University; Social & Scientific Systems Inc; Soligenix, Inc.; Teleflex; UNT Health Science Center; UNTHSC, PreClinical Services; Visterra; Weber Shandwick;

ANDREW TOMARAS

VP and Director of Microbiology, BacterioScan Inc. Andrew Tomaras

ANTHONY SIMON LYNCH

Senior Scientific Director, Janssen Fellow & Incubator Leader, Janssen Anthony Simon Lynch

ANTONIO DIGIANDONEICO

Principal Scientist, MedImmune Antonio DiGiandoneico

BRENT CEZAIRLIYAN

Senior Scientist, Octagon Therapeutics Brent Cezairliyan

DANIEL PEVEAR

Sr. Vice President of Biology and Grants Development, Venatorx Pharmaceuticals Daniel Pevear

EVAN HECKER

Director of API Development, Spero therapeutics Evan Hecker

IAN FRIEDLAND

Clinical Consultant, Ex-Chief Medical Officer, Achaogen Ian Friedland

JOE NEWMAN

Senior Director, Head of Biology, Tetraphase Pharmaceuticals

USD

Group registrations not allowed

Accompanying persons not allowed

We don’t accept Online Abstracts

RENAISSANCE WOODBRIDGE HOTEL

515 US Highway 1 South, Iselin, New Jersey, USA

Your simple delights will become memorable moments at Renaissance Woodbridge Hotel. This distinctive hotel in Edison, New Jersey, features 269 modern guest rooms, including 42 suites, and more than 25,000 square feet of flexible meeting space. Our hotel's location is centrally located amidst corporate offices and tourist attraction. Our accommodations stand out from other hotels in Edison, NJ, and provide a sophisticated retreat for families and business travelers alike. Marriott's Plug-in panels and 37-inch LCD HD TVs allow guests simultaneous connectivity to laptops, iPods and DVD players. We are one of the most conveniently situated hotels at the crossroads of U.S. Routes 1 and 9. We are also just five minutes from Woodbridge Center Mall, 15 minutes south of Newark Liberty International Airport (EWR) and less than one mile from the Metropark train station. With our premier location and amenities, our Edison accommodations provide an advantageous travel destination.

Submission Info

+44 (0)20 7827 6000 

events@smi-online.co.uk

SCYNEXIS

Sponsors and Exhibitors

SCYNEXIS, Inc. (NASDAQ: SCYX) is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. The SCYNEXIS team has extensive experience in the life sciences industry, discovering and developing more than 30 innovative medicines over a broad range of therapeutic areas. The Company's lead product candidate, SCY-078, is a novel IV/oral antifungal agent in Phase 2 clinical and preclinical development for the treatment of several serious and life-threatening invasive fungal infections caused by Candida and Aspergillus species. For more information, visit www.scynexis.com.

events@smi-online.co.uk